KEQU Kewaunee Scientific Corporation

33.84USD+0.36%Mkt Cap: 97.98M $P/E: 12.26

Kewaunee Scientific Corporation, together with its subsidiaries, designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products in the United States and internationally. I…

HeadlineSourceTime
Older
Kewaunee Q1 Earnings Fall Y/Y Despite International Strength

KEQU's fiscal Q1 results reflect weaker sales and LPG volumes, partly offset by stronger international profitability and cost control.

Zacks
Kewaunee Scientific Posts Record $282M Revenue, Maps Fiscal 2027 Growth Investments

Kewaunee Scientific (NASDAQ:KEQU) reported record revenue and outlined continued investments in product development, manufacturing capacity, international expansion and potential acquisitions during its 2026 annual meeting of stockholders. President and Chief Executive Officer Thomas D. Hull III sa

MarketBeat
The Zacks Analyst Blog Highlights Eli Lilly, Costco Wholesale, Morgan Stanley and Kewaunee Scientific

Eli Lilly's expanding GLP-1 portfolio and pipeline remain in focus as demand stays strong ahead of its second-quarter earnings results.

Zacks
Top Research Reports for Eli Lilly, Costco & Morgan Stanley

Eli Lilly's GLP-1 portfolio, pipeline progress and 2026 acquisitions are driving growth despite pricing pressure and rising competition.

Zacks